FILTER
LATEST ARTICLES
B.C. Mining Enters an Era of Reconciliation
February 13, 2019
True cohesion between government, Indigenous groups and the sector is the priority.
Metals and Materials of the Future
February 13, 2019
Lithium and vanadium projects are attracting substantial investment.
Standing Out in the Biotech Crowd: The VC Investment Climate
February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.
The Mining Value Chain: 2019 Trends Driving Service Providers
February 05, 2019
Africa’s service providers are rising to the task of providing turnkey solutions and bringing the latest innovations to the continent.
The Delicate Balancing Act of Developing ‘Vogue Minerals’ Projects
February 05, 2019
Expert Opinion Article contributed by SRK Consulting’s global team of consultants.
Turkey’s 21st Century Coal Rush
December 27, 2018
Turkey favors coal development to reach energy self-sufficiency
Toronto’s Financial District
December 27, 2018
Toronto continues to be the investment engine of global mining, despite new competition from cannabis, blockchain and cryptocurrencies.
Improving Competitiveness for Brazil’s Chemical Industry
December 13, 2018
A quick look at the sector as Jair Bolsonaro becomes the new president.
Prosperity or Penury – Singapore's Petrochemicals Industry Faces Challenges to Re-invent Itself
December 13, 2018
Expert Opinion Article by Steve Jenkins, VP Chemicals Consulting Asia Pacific, PCI Wood Mackenzie.
ARA - France's Other Aerospace Valley
December 06, 2018
The region boasts a strong offering to the aerospace industry, as it is home to a large number of thriving Tier 1 and Tier 2 suppliers for OEMs, as well as many SMEs offering more niche products.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
